Concurrent Chemoradiotherapy

Known as: Chemoradiotherapy, Synchronous, Concurrent Chemoradiotherapies, Chemoradiotherapies, Synchronous 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
02040608020012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Given the lack of studies, whether the addition of adjuvant chemotherapy (AC) to concurrent chemoradiotherapy (CCRT… (More)
  • table 1
  • figure 1
Is this relevant?
2014
2014
BACKGROUND Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients with unresectable, nonmetastatic… (More)
  • figure 2
Is this relevant?
2014
2014
BACKGROUND AND PURPOSE To evaluate long-term outcome in locoregionally advanced nasopharyngeal carcinoma (NPC) treated with… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • table 5
Is this relevant?
2013
2013
PURPOSE To investigate the changes in apparent diffusion coefficients (ADCs) in cervical cancer patients receiving concurrent… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 3
Is this relevant?
2011
2011
BACKGROUNDS There are limitations in using only radiological criteria to evaluate treatment outcomes in hepatocellular carcinoma… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2010
2010
PURPOSE Assess efficacy and toxicity of gefitinib, an epidermal growth factor receptor (EGFR) inhibitor, added to, and in… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
OBJECTIVE On the basis of outcome data from concurrent chemoradiotherapy (CCRT) for locally advanced cervical squamous cell… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2009
2009
BACKGROUND To investigate the prognostic value of volumetric analysis in patients with stage III-IVA hypopharyngeal cancer… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Concurrent chemoradiotherapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN) increases both local tumor… (More)
  • table 1
  • figure 1
  • table 2
  • table 4
Is this relevant?
2008
2008
BACKGROUND Excision repair cross-complementation Group 1 (ERCC1) overexpression is associated with resistance to cisplatin-based… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?